ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003